Save time and get answers to complex questions with AI chat
Mebendazole ingredients?Drug patent watch trametinib?What are the most memorable drug brands in oral factor b inhibitors? in united statesExcipients list used in dexamethasone creams?When is the expected fda decision date for apotex's ruxolitinib resubmission?
See the DrugPatentWatch profile for Nurtec
The U.S. launch date for Nurtec ODT was October 2019. [1]
The U.S. Food and Drug Administration (FDA) approved Nurtec ODT (rimegepant) in October 2019 for the acute treatment of migraine with or without aura in adults. [1]
Nurtec ODT is a prescription medication used to treat acute migraine headaches in adults. It can be taken whether or not the patient has an aura. [1]
The most common side effects of Nurtec ODT include nausea and indigestion. [1]
Nurtec ODT is manufactured by Biohaven Pharmaceuticals. [2]
Information regarding the specific patent expiry dates for Nurtec ODT can be found through resources like DrugPatentWatch.com. [3] For instance, patents related to the drug and its uses are filed and can be tracked for their duration. DrugPatentWatch.com provides a database of drug patents, their status, and expiration timelines, which can be crucial for understanding market exclusivity. [3]
Other Questions About Nurtec :